C8 Sciences

C8’s goal is to become the leading global developer of neuroscience-based brain-training programs to enhance the lives of millions of children and adults.

  • Stage $500K in TTM Revenue
  • Industry Healthcare Services
  • Location New Haven, CT, US
  • Currency USD
  • Founded April 2011
  • Employees 8
  • Website c8sciences.com

Company Summary

C8 Sciences develops brain-training programs that can solve some of the most significant problems in childhood education and our aging population.
Our cloud-based SaaS solutions are based on proprietary research developed at Yale University. Today we successfully support thousands of students who have ADHD and Executive Function disorders. We are fast becoming recognized as the leading provider offering “non-pharmacologic treatment for ADHD.”

Team

  • Jeffrey Vohden
    Chief Executive Officer

  • Kenneth Coleman
    EVP Finance & Admin

  • Bruce Wexler
    Board Chairman, Chief Scientist

  • Matt Fitzpatrick
    VP Product Management

Advisors

  • Kevin Custer
    Board Vice Chairman, CEO of Arc Capital Development
    Unconfirmed
    William Zaggle
    Director
    Chris Penner
    Director, Managing Director Connecticut Innovations Inc.
    Unconfirmed
  • Seth Feuerstein
    Director, Healthcare Advisor
    Unconfirmed
    Benjamin Bunney
    Director, Healthcare Advisor
    Unconfirmed

Previous Investors

  • Connecticut Innovations, Inc.
    shareholder
    Unconfirmed
    Konstantine Drakonakis
    shareholder
    Arc Capital Management
    Vice Chairman
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free